Dose-dependent targeting of 89Zr-labeled atezolizumab (anti-PD-L1 antibody) to PD-L1 expressing tumor xenografts

被引：0
|
作者：
Longtine, Mark [1 ]
Wahl, Richard [1 ]
机构：
[1] Mallinckrodt Inst Radiol, St Louis, MO USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1105
引用
收藏
页数：2
相关论文
共 50 条
  • [21] 89Zr-labeled anti-PD-1 antibody for in vivo monitoring of infiltrating PD-1+ T lymphocytes in a pancreatic tumor mouse model
    Liu, Liang
    Geller, Anne
    Yan, Jun
    Guo, Haixun
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [22] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Jiming Chen
    Jie Yang
    Wenhui Wang
    Danfeng Guo
    Chengyan Zhang
    Shibo Wang
    Xinliang Lu
    Xiaofang Huang
    Pingli Wang
    Gensheng Zhang
    Jing Zhang
    Jianli Wang
    Zhijian Cai
    Cellular & Molecular Immunology, 2022, 19 : 1290 - 1301
  • [23] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Chen, Jiming
    Yang, Jie
    Wang, Wenhui
    Guo, Danfeng
    Zhang, Chengyan
    Wang, Shibo
    Lu, Xinliang
    Huang, Xiaofang
    Wang, Pingli
    Zhang, Gensheng
    Zhang, Jing
    Wang, Jianli
    Cai, Zhijian
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (11) : 1290 - 1301
  • [24] Targeting the intrinsic signaling of PD-L1 in human monocytes by a novel PD-L1 antibody to promote anti-tumor immunity.
    Hsu, Michelle A.
    Liu, Xin
    Barham, Whitney
    Hirdler, Jacob
    Mao, Zhiming
    Lucien, Fabrice
    Dong, Haidong
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [25] Anti-PD-L1 DNA aptamer antagonizes the interaction of PD-1/PD-L1 with antitumor effect
    Gao, Tian
    Mao, Zheng
    Li, Wenjing
    Pei, Renjun
    JOURNAL OF MATERIALS CHEMISTRY B, 2021, 9 (03) : 746 - 756
  • [26] Immuno PET imaging of PD-L1 expression in syngeneic and human xenograft tumor mouse models using a site-specific 89Zr labeled PD-L1 antibody
    Christensen, Camilla
    Kristensen, Lotte K.
    Toftevall, Hanna
    Nordgren, Maria
    Agnew, Brian J.
    Nielsen, Carsten H.
    Kjaer, Andreas
    CANCER RESEARCH, 2018, 78 (13)
  • [27] Effect of NK cell treatment on PD-L1 expression and anti-PD-L1 response
    Copik, Alicja
    Oyer, Jeremiah
    Gitto, Sarah
    Altomare, Deborah
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [28] Resistance to anti-PD-1/anti-PD-L1: GB1211 reverses galectin-3 induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1
    Mabbitt, Joseph
    Roper, James A.
    Slack, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] Evaluation of 89Zr-Labeled Anti-PD-L1 Monoclonal Antibodies Using DFO and Novel HOPO Analogues as Chelating Agents for Immuno-PET
    Radaram, Bhasker
    Glazer, Sarah E.
    Yang, Ping
    Li, Chia-Wei
    Hung, Mien-Chie
    Gammon, Seth T.
    Alauddin, Mian
    Piwnica-Worms, David
    ACS OMEGA, 2023, 8 (19): : 17181 - 17194
  • [30] 89Zr-labeled anti-PD-L1 Probody therapeutic CX-072 biodistribution in mice bearing human xenograft or murine syngeneic tumors
    Giesen, Danique
    Broer, Linda N.
    Lub-de Hooge, Marjolijn N.
    Popova, Irina
    Howng, Bruce
    Vasiljeva, Olga
    de Vries, Elisabeth G.
    Pool, Martin
    CANCER RESEARCH, 2018, 78 (13)
12345